Page 24 - 南京医科大学学报自然科学版
P. 24

第42卷第7期
               ·920 ·                            南 京    医 科 大 学 学         报                        2022年7月


                   2017,38(11):793-804                          [17] NIKOLIC T,ZWAGINGA J J,UITBEIJERSE B S,et al.
             [11]OCTAVIO M P,FEDERICO F,ESTEBAN B,et al. Toler⁃      Safety and feasibility of intradermal injection with tolero⁃
                   ogenic dendritic cells in autoimmunity and inflammatory  genic dendritic cells pulsed with proinsulin peptide ⁃ for
                   diseases[J]. Trends Immunol,2021,42(1):59-75      type 1 diabetes[J]. Lancet Diabetes Endocrinol,2020,8
             [12] DE JESÚS RÍOS⁃RÍOS W,SOSA⁃LUIS S A,TORRES⁃         (6):470-472
                   AGUILAR H. Current advances in using tolerogenic den⁃  [18] FUNDA D P,GOLIÁŠ J,HUDCOVIC T,et al. Antigen
                   dritic cells as a therapeutic alternative in the treatment of  loading(e.g.,glutamic acid decarboxylase 65)of tolero⁃
                   type 1 diabetes[J]. World J Diabetes,2021,12(5):603-  genic DCs(tolDCs)reduces their capacity to prevent dia⁃
                   615                                               betes in the non⁃obese diabetes(NOD)⁃severe combined
             [13] PHILLIPS B E,GARCIAFIGUEROA Y,TRUCCO M,et          immunodeficiency model of adoptive cotransfer of diabe⁃
                   al. Clinical tolerogenic dendritic cells:exploring therapeu⁃  tes as well as in NOD mice[J]. Front Immunol,2018,9:
                   tic impact on human autoimmune disease[J]. Front Im⁃  290
                   munol,2017,8:1279                            [19] 曹  维,季琝君,邢春燕,等. 胰岛素B9⁃23多肽对树突
             [14] FUNDA D P,PALOVÁ⁃JELÍNKOVÁ L,GOLIÁŠ J,et al.       状细胞表型及功能的影响[J]. 南京医科大学学报(自
                   Optimal tolerogenic dendritic cells in type 1 diabetes  然科学版),2010,30(7):914-918
                  (T1D)therapy:what can we learn from non⁃obese diabetic  [20] ANDERSON A E,SWAN D J,SAYERS B L,et al. LPS
                  (NOD)mouse models?[J]. Front Immunol,2019,10:967   activation is required for migratory activity and antigen
             [15] HASKINS K. Pathogenic T⁃cell clones in autoimmune dia⁃  presentation by tolerogenic dendritic cells[J]. J Leukoc
                   betes:more lessons from the NOD mouse[J]. Adv Immu⁃  Biol,2009,85(2):243-250
                   nol,2005,87:123-162                          [21] KIM M,KIM J. Properties of immature and mature den⁃
             [16] SUWANDI J S,LABAN S,VASS K,et al. Multidimen⁃      dritic cells:phenotype,morphology,phagocytosis,and
                   sional analyses of proinsulin peptide⁃specific regulatory T  migration[J]. RSC Advances,2019,9:11230-11238
                   cells induced by tolerogenic dendritic cells[J]. J Autoim⁃             [收稿日期] 2022-01-27
                   mun,2020,107:102361                                                         (责任编辑:蒋      莉)








                                                                                                 

















                              欢迎关注我刊微博、微信公众号!






                              
   19   20   21   22   23   24   25   26   27   28   29